nodes	percent_of_prediction	percent_of_DWPC	metapath
Pazopanib—UGT1A1—Indacaterol—asthma	0.0667	0.133	CbGbCtD
Pazopanib—ABCG2—Zafirlukast—asthma	0.0267	0.0534	CbGbCtD
Pazopanib—CYP2C8—Salmeterol—asthma	0.0182	0.0363	CbGbCtD
Pazopanib—CYP2C8—Mometasone—asthma	0.0182	0.0363	CbGbCtD
Pazopanib—ABCB1—Fluticasone furoate—asthma	0.0162	0.0324	CbGbCtD
Pazopanib—CYP2C8—Zafirlukast—asthma	0.0142	0.0284	CbGbCtD
Pazopanib—ABCB1—Indacaterol—asthma	0.0132	0.0264	CbGbCtD
Pazopanib—CYP1A2—Zileuton—asthma	0.0125	0.025	CbGbCtD
Pazopanib—CYP2D6—Ciclesonide—asthma	0.0125	0.0249	CbGbCtD
Pazopanib—CYP1A2—Zafirlukast—asthma	0.011	0.022	CbGbCtD
Pazopanib—CYP2C8—Theophylline—asthma	0.011	0.022	CbGbCtD
Pazopanib—ABCG2—Hydrocortisone—asthma	0.0109	0.0217	CbGbCtD
Pazopanib—CYP2C8—Loratadine—asthma	0.0104	0.0208	CbGbCtD
Pazopanib—CYP2C8—Montelukast—asthma	0.0104	0.0208	CbGbCtD
Pazopanib—CYP2D6—Ipratropium bromide—asthma	0.0103	0.0206	CbGbCtD
Pazopanib—CYP3A4—Fluticasone furoate—asthma	0.00972	0.0194	CbGbCtD
Pazopanib—CYP2D6—Zafirlukast—asthma	0.00909	0.0181	CbGbCtD
Pazopanib—CYP1A2—Aminophylline—asthma	0.00906	0.0181	CbGbCtD
Pazopanib—CYP2D6—Arformoterol—asthma	0.00878	0.0175	CbGbCtD
Pazopanib—CYP2D6—Formoterol—asthma	0.00878	0.0175	CbGbCtD
Pazopanib—CYP3A4—Budesonide—asthma	0.00866	0.0173	CbGbCtD
Pazopanib—CYP1A2—Theophylline—asthma	0.00852	0.017	CbGbCtD
Pazopanib—CYP3A4—Ciclesonide—asthma	0.00792	0.0158	CbGbCtD
Pazopanib—CYP3A4—Indacaterol—asthma	0.00792	0.0158	CbGbCtD
Pazopanib—CYP2D6—Tiotropium—asthma	0.00782	0.0156	CbGbCtD
Pazopanib—CYP3A4—Salbutamol—asthma	0.00736	0.0147	CbGbCtD
Pazopanib—CYP3A4—Flunisolide—asthma	0.00736	0.0147	CbGbCtD
Pazopanib—CYP3A4—Salmeterol—asthma	0.00736	0.0147	CbGbCtD
Pazopanib—ABCB1—Loratadine—asthma	0.00706	0.0141	CbGbCtD
Pazopanib—CYP2D6—Theophylline—asthma	0.00702	0.014	CbGbCtD
Pazopanib—ABCG2—Dexamethasone—asthma	0.00677	0.0135	CbGbCtD
Pazopanib—CYP2D6—Loratadine—asthma	0.00665	0.0133	CbGbCtD
Pazopanib—CYP3A4—Zileuton—asthma	0.00656	0.0131	CbGbCtD
Pazopanib—CYP3A4—Ipratropium bromide—asthma	0.00656	0.0131	CbGbCtD
Pazopanib—ABCB1—Methylprednisolone—asthma	0.00646	0.0129	CbGbCtD
Pazopanib—CYP3A4—Fluticasone Propionate—asthma	0.00626	0.0125	CbGbCtD
Pazopanib—CYP2C8—Hydrocortisone—asthma	0.0058	0.0116	CbGbCtD
Pazopanib—CYP3A4—Zafirlukast—asthma	0.00578	0.0115	CbGbCtD
Pazopanib—CYP3A4—Tiotropium—asthma	0.00497	0.00993	CbGbCtD
Pazopanib—CYP3A4—Aminophylline—asthma	0.00474	0.00947	CbGbCtD
Pazopanib—CYP3A4—Theophylline—asthma	0.00446	0.00891	CbGbCtD
Pazopanib—CYP3A4—Loratadine—asthma	0.00423	0.00844	CbGbCtD
Pazopanib—CYP3A4—Montelukast—asthma	0.00423	0.00844	CbGbCtD
Pazopanib—ABCB1—Betamethasone—asthma	0.0042	0.00838	CbGbCtD
Pazopanib—ABCB1—Prednisolone—asthma	0.00414	0.00827	CbGbCtD
Pazopanib—ABCB1—Hydrocortisone—asthma	0.00393	0.00784	CbGbCtD
Pazopanib—ABCB1—Prednisone—asthma	0.00391	0.00781	CbGbCtD
Pazopanib—CYP3A4—Methylprednisolone—asthma	0.00387	0.00772	CbGbCtD
Pazopanib—CYP2C8—Dexamethasone—asthma	0.00361	0.0072	CbGbCtD
Pazopanib—CYP3A4—Triamcinolone—asthma	0.00293	0.00585	CbGbCtD
Pazopanib—CYP3A4—Betamethasone—asthma	0.00252	0.00502	CbGbCtD
Pazopanib—CYP3A4—Prednisolone—asthma	0.00248	0.00495	CbGbCtD
Pazopanib—ABCB1—Dexamethasone—asthma	0.00244	0.00488	CbGbCtD
Pazopanib—CYP3A4—Hydrocortisone—asthma	0.00235	0.0047	CbGbCtD
Pazopanib—CYP3A4—Prednisone—asthma	0.00234	0.00468	CbGbCtD
Pazopanib—CYP2D6—Dexamethasone—asthma	0.0023	0.00459	CbGbCtD
Pazopanib—MAP3K9—epithelium—asthma	0.00184	0.0161	CbGeAlD
Pazopanib—TAOK1—respiratory system—asthma	0.00165	0.0144	CbGeAlD
Pazopanib—FGFR2—exocrine gland—asthma	0.00164	0.0143	CbGeAlD
Pazopanib—ITK—bronchus—asthma	0.00149	0.013	CbGeAlD
Pazopanib—CYP3A4—Dexamethasone—asthma	0.00146	0.00292	CbGbCtD
Pazopanib—PLK4—respiratory system—asthma	0.0014	0.0122	CbGeAlD
Pazopanib—TAOK1—bronchus—asthma	0.00136	0.0119	CbGeAlD
Pazopanib—MAP3K9—adrenal gland—asthma	0.00133	0.0116	CbGeAlD
Pazopanib—SH2B3—adrenal cortex—asthma	0.00131	0.0114	CbGeAlD
Pazopanib—FGFR3—respiratory system—asthma	0.0013	0.0114	CbGeAlD
Pazopanib—MAP3K19—respiratory system—asthma	0.00129	0.0112	CbGeAlD
Pazopanib—SH2B3—bronchus—asthma	0.00128	0.0112	CbGeAlD
Pazopanib—SH2B3—cardiovascular system—asthma	0.00119	0.0104	CbGeAlD
Pazopanib—MAP3K9—lung—asthma	0.00117	0.0102	CbGeAlD
Pazopanib—PI4KB—respiratory system—asthma	0.00115	0.0101	CbGeAlD
Pazopanib—SH2B3—trachea—asthma	0.00115	0.01	CbGeAlD
Pazopanib—KIT—exocrine gland—asthma	0.00114	0.00992	CbGeAlD
Pazopanib—LIMK2—respiratory system—asthma	0.00113	0.00987	CbGeAlD
Pazopanib—ITK—adrenal gland—asthma	0.0011	0.0096	CbGeAlD
Pazopanib—FGFR3—epithelium—asthma	0.00109	0.0095	CbGeAlD
Pazopanib—BMPR1B—epithelium—asthma	0.00108	0.0094	CbGeAlD
Pazopanib—FGFR3—bronchus—asthma	0.00107	0.00935	CbGeAlD
Pazopanib—BMPR1B—bronchus—asthma	0.00106	0.00926	CbGeAlD
Pazopanib—FLT4—respiratory system—asthma	0.00102	0.00887	CbGeAlD
Pazopanib—TAOK1—adrenal gland—asthma	0.001	0.00874	CbGeAlD
Pazopanib—STK36—adrenal cortex—asthma	0.000982	0.00857	CbGeAlD
Pazopanib—PI4KB—adrenal cortex—asthma	0.000967	0.00844	CbGeAlD
Pazopanib—ITK—lung—asthma	0.000964	0.00841	CbGeAlD
Pazopanib—STK36—bronchus—asthma	0.000963	0.0084	CbGeAlD
Pazopanib—PI4KB—bronchus—asthma	0.000948	0.00827	CbGeAlD
Pazopanib—SH2B3—adrenal gland—asthma	0.000943	0.00823	CbGeAlD
Pazopanib—LIMK2—bronchus—asthma	0.000931	0.00812	CbGeAlD
Pazopanib—AURKC—adrenal gland—asthma	0.000928	0.0081	CbGeAlD
Pazopanib—PI4KB—smooth muscle tissue—asthma	0.000928	0.00809	CbGeAlD
Pazopanib—FGF1—respiratory system—asthma	0.000903	0.00788	CbGeAlD
Pazopanib—TAOK1—lung—asthma	0.000878	0.00766	CbGeAlD
Pazopanib—STK36—trachea—asthma	0.000865	0.00754	CbGeAlD
Pazopanib—FLT4—adrenal cortex—asthma	0.000853	0.00744	CbGeAlD
Pazopanib—FGFR2—respiratory system—asthma	0.000853	0.00744	CbGeAlD
Pazopanib—PI4KB—trachea—asthma	0.000851	0.00743	CbGeAlD
Pazopanib—FLT4—epithelium—asthma	0.00085	0.00741	CbGeAlD
Pazopanib—PLK4—adrenal gland—asthma	0.000849	0.00741	CbGeAlD
Pazopanib—PIP4K2C—adrenal cortex—asthma	0.000848	0.0074	CbGeAlD
Pazopanib—LIMK2—trachea—asthma	0.000836	0.00729	CbGeAlD
Pazopanib—PIP4K2C—bronchus—asthma	0.000832	0.00726	CbGeAlD
Pazopanib—SH2B3—lung—asthma	0.000826	0.00721	CbGeAlD
Pazopanib—FGFR1—bronchus—asthma	0.000825	0.0072	CbGeAlD
Pazopanib—STK16—adrenal gland—asthma	0.000802	0.00699	CbGeAlD
Pazopanib—FLT1—respiratory system—asthma	0.00079	0.0069	CbGeAlD
Pazopanib—RIOK2—adrenal gland—asthma	0.000789	0.00688	CbGeAlD
Pazopanib—FGFR3—adrenal gland—asthma	0.000789	0.00688	CbGeAlD
Pazopanib—BMPR1B—adrenal gland—asthma	0.000781	0.00682	CbGeAlD
Pazopanib—FLT4—cardiovascular system—asthma	0.000779	0.00679	CbGeAlD
Pazopanib—FGF1—epithelium—asthma	0.000755	0.00658	CbGeAlD
Pazopanib—STK10—respiratory system—asthma	0.000748	0.00653	CbGeAlD
Pazopanib—PIP4K2C—trachea—asthma	0.000747	0.00652	CbGeAlD
Pazopanib—TAOK3—respiratory system—asthma	0.000745	0.0065	CbGeAlD
Pazopanib—PLK4—lung—asthma	0.000744	0.00649	CbGeAlD
Pazopanib—PDGFRA—respiratory system—asthma	0.000741	0.00646	CbGeAlD
Pazopanib—LCK—bronchus—asthma	0.000739	0.00644	CbGeAlD
Pazopanib—FGF1—smooth muscle tissue—asthma	0.000727	0.00634	CbGeAlD
Pazopanib—FGFR2—epithelium—asthma	0.000713	0.00622	CbGeAlD
Pazopanib—STK36—adrenal gland—asthma	0.000709	0.00618	CbGeAlD
Pazopanib—STK16—lung—asthma	0.000703	0.00613	CbGeAlD
Pazopanib—PI4KB—adrenal gland—asthma	0.000698	0.00609	CbGeAlD
Pazopanib—FGFR3—lung—asthma	0.000692	0.00603	CbGeAlD
Pazopanib—RIOK2—lung—asthma	0.000692	0.00603	CbGeAlD
Pazopanib—FGF1—cardiovascular system—asthma	0.000692	0.00603	CbGeAlD
Pazopanib—FGFR2—smooth muscle tissue—asthma	0.000687	0.00599	CbGeAlD
Pazopanib—LIMK2—adrenal gland—asthma	0.000685	0.00598	CbGeAlD
Pazopanib—MAP3K19—lung—asthma	0.000685	0.00597	CbGeAlD
Pazopanib—BMPR1B—lung—asthma	0.000685	0.00597	CbGeAlD
Pazopanib—KDR—respiratory system—asthma	0.000668	0.00583	CbGeAlD
Pazopanib—FLT1—adrenal cortex—asthma	0.000663	0.00579	CbGeAlD
Pazopanib—LCK—trachea—asthma	0.000663	0.00579	CbGeAlD
Pazopanib—FLT1—epithelium—asthma	0.000661	0.00576	CbGeAlD
Pazopanib—FGFR2—cardiovascular system—asthma	0.000653	0.0057	CbGeAlD
Pazopanib—CSF1R—respiratory system—asthma	0.000652	0.00569	CbGeAlD
Pazopanib—FLT1—bronchus—asthma	0.00065	0.00567	CbGeAlD
Pazopanib—EPHB6—bronchus—asthma	0.000643	0.00561	CbGeAlD
Pazopanib—FLT1—smooth muscle tissue—asthma	0.000636	0.00555	CbGeAlD
Pazopanib—TAOK3—adrenal cortex—asthma	0.000626	0.00546	CbGeAlD
Pazopanib—STK36—lung—asthma	0.000621	0.00542	CbGeAlD
Pazopanib—FLT4—adrenal gland—asthma	0.000616	0.00537	CbGeAlD
Pazopanib—STK10—bronchus—asthma	0.000616	0.00537	CbGeAlD
Pazopanib—TAOK3—bronchus—asthma	0.000613	0.00535	CbGeAlD
Pazopanib—PIP4K2C—adrenal gland—asthma	0.000612	0.00534	CbGeAlD
Pazopanib—PI4KB—lung—asthma	0.000612	0.00534	CbGeAlD
Pazopanib—FGFR1—adrenal gland—asthma	0.000608	0.0053	CbGeAlD
Pazopanib—FLT1—cardiovascular system—asthma	0.000605	0.00528	CbGeAlD
Pazopanib—LIMK2—lung—asthma	0.000601	0.00524	CbGeAlD
Pazopanib—PDGFRA—smooth muscle tissue—asthma	0.000596	0.0052	CbGeAlD
Pazopanib—KIT—respiratory system—asthma	0.000592	0.00517	CbGeAlD
Pazopanib—FLT1—trachea—asthma	0.000584	0.0051	CbGeAlD
Pazopanib—MAP3K2—adrenal gland—asthma	0.000581	0.00507	CbGeAlD
Pazopanib—PDGFRB—respiratory system—asthma	0.000578	0.00505	CbGeAlD
Pazopanib—EPHB6—trachea—asthma	0.000577	0.00504	CbGeAlD
Pazopanib—STK10—cardiovascular system—asthma	0.000573	0.005	CbGeAlD
Pazopanib—TAOK3—cardiovascular system—asthma	0.000571	0.00498	CbGeAlD
Pazopanib—PDGFRA—cardiovascular system—asthma	0.000567	0.00495	CbGeAlD
Pazopanib—KDR—adrenal cortex—asthma	0.000561	0.00489	CbGeAlD
Pazopanib—MAP2K5—adrenal cortex—asthma	0.000561	0.00489	CbGeAlD
Pazopanib—KDR—epithelium—asthma	0.000558	0.00487	CbGeAlD
Pazopanib—TAOK3—trachea—asthma	0.000551	0.00481	CbGeAlD
Pazopanib—KDR—bronchus—asthma	0.00055	0.0048	CbGeAlD
Pazopanib—MAP2K5—bronchus—asthma	0.00055	0.0048	CbGeAlD
Pazopanib—PDGFRA—trachea—asthma	0.000547	0.00477	CbGeAlD
Pazopanib—CSF1R—adrenal cortex—asthma	0.000547	0.00477	CbGeAlD
Pazopanib—FGF1—adrenal gland—asthma	0.000547	0.00477	CbGeAlD
Pazopanib—LCK—adrenal gland—asthma	0.000544	0.00474	CbGeAlD
Pazopanib—FLT4—lung—asthma	0.00054	0.00471	CbGeAlD
Pazopanib—KDR—smooth muscle tissue—asthma	0.000538	0.00469	CbGeAlD
Pazopanib—PIP4K2C—lung—asthma	0.000537	0.00468	CbGeAlD
Pazopanib—CSF1R—bronchus—asthma	0.000537	0.00468	CbGeAlD
Pazopanib—FGFR1—lung—asthma	0.000532	0.00465	CbGeAlD
Pazopanib—CSF1R—smooth muscle tissue—asthma	0.000525	0.00458	CbGeAlD
Pazopanib—FGFR2—adrenal gland—asthma	0.000517	0.00451	CbGeAlD
Pazopanib—KDR—cardiovascular system—asthma	0.000512	0.00446	CbGeAlD
Pazopanib—MAP2K5—cardiovascular system—asthma	0.000512	0.00446	CbGeAlD
Pazopanib—MAP3K2—lung—asthma	0.000509	0.00444	CbGeAlD
Pazopanib—CSF1R—cardiovascular system—asthma	0.000499	0.00436	CbGeAlD
Pazopanib—KIT—epithelium—asthma	0.000495	0.00432	CbGeAlD
Pazopanib—MAP2K5—trachea—asthma	0.000494	0.00431	CbGeAlD
Pazopanib—KDR—trachea—asthma	0.000494	0.00431	CbGeAlD
Pazopanib—KIT—bronchus—asthma	0.000487	0.00425	CbGeAlD
Pazopanib—PDGFRB—adrenal cortex—asthma	0.000485	0.00423	CbGeAlD
Pazopanib—PDGFRB—epithelium—asthma	0.000483	0.00422	CbGeAlD
Pazopanib—CSF1R—trachea—asthma	0.000482	0.0042	CbGeAlD
Pazopanib—FGF1—lung—asthma	0.000479	0.00418	CbGeAlD
Pazopanib—FLT1—adrenal gland—asthma	0.000479	0.00418	CbGeAlD
Pazopanib—KIT—smooth muscle tissue—asthma	0.000477	0.00416	CbGeAlD
Pazopanib—LCK—lung—asthma	0.000477	0.00416	CbGeAlD
Pazopanib—PDGFRB—bronchus—asthma	0.000476	0.00415	CbGeAlD
Pazopanib—EPHB6—adrenal gland—asthma	0.000473	0.00413	CbGeAlD
Pazopanib—PDGFRB—smooth muscle tissue—asthma	0.000466	0.00406	CbGeAlD
Pazopanib—KIT—cardiovascular system—asthma	0.000453	0.00396	CbGeAlD
Pazopanib—STK10—adrenal gland—asthma	0.000453	0.00395	CbGeAlD
Pazopanib—FGFR2—lung—asthma	0.000453	0.00395	CbGeAlD
Pazopanib—TAOK3—adrenal gland—asthma	0.000452	0.00394	CbGeAlD
Pazopanib—PDGFRA—adrenal gland—asthma	0.000449	0.00391	CbGeAlD
Pazopanib—PDGFRB—cardiovascular system—asthma	0.000443	0.00386	CbGeAlD
Pazopanib—KIT—trachea—asthma	0.000438	0.00382	CbGeAlD
Pazopanib—PDGFRB—trachea—asthma	0.000427	0.00373	CbGeAlD
Pazopanib—FLT1—lung—asthma	0.00042	0.00366	CbGeAlD
Pazopanib—EPHB6—lung—asthma	0.000415	0.00362	CbGeAlD
Pazopanib—KDR—adrenal gland—asthma	0.000405	0.00353	CbGeAlD
Pazopanib—MAP2K5—adrenal gland—asthma	0.000405	0.00353	CbGeAlD
Pazopanib—STK10—lung—asthma	0.000397	0.00347	CbGeAlD
Pazopanib—TAOK3—lung—asthma	0.000396	0.00345	CbGeAlD
Pazopanib—CSF1R—adrenal gland—asthma	0.000395	0.00345	CbGeAlD
Pazopanib—PDGFRA—lung—asthma	0.000393	0.00343	CbGeAlD
Pazopanib—KIT—adrenal gland—asthma	0.000359	0.00313	CbGeAlD
Pazopanib—KDR—lung—asthma	0.000355	0.0031	CbGeAlD
Pazopanib—MAP2K5—lung—asthma	0.000355	0.0031	CbGeAlD
Pazopanib—PDGFRB—adrenal gland—asthma	0.00035	0.00306	CbGeAlD
Pazopanib—CSF1R—lung—asthma	0.000346	0.00302	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Fluticasone furoate—asthma	0.000319	0.0794	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Fluticasone furoate—asthma	0.000319	0.0794	CbGdCrCtD
Pazopanib—KIT—lung—asthma	0.000314	0.00274	CbGeAlD
Pazopanib—CYP1A2—respiratory system—asthma	0.000313	0.00273	CbGeAlD
Pazopanib—PDGFRB—lung—asthma	0.000307	0.00268	CbGeAlD
Pazopanib—SH2B3—Betamethasone—Fluticasone Propionate—asthma	0.000298	0.074	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Fluticasone Propionate—asthma	0.000298	0.074	CbGdCrCtD
Pazopanib—ABCG2—adrenal cortex—asthma	0.000273	0.00238	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Beclomethasone—asthma	0.000219	0.0544	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Beclomethasone—asthma	0.000219	0.0544	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Budesonide—asthma	0.00021	0.0522	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Budesonide—asthma	0.00021	0.0522	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Flunisolide—asthma	0.000207	0.0515	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Flunisolide—asthma	0.000207	0.0515	CbGdCrCtD
Pazopanib—ABCG2—adrenal gland—asthma	0.000197	0.00172	CbGeAlD
Pazopanib—ABCG2—lung—asthma	0.000173	0.00151	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Mometasone—asthma	0.00017	0.0422	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Mometasone—asthma	0.00017	0.0422	CbGdCrCtD
Pazopanib—CYP1A2—lung—asthma	0.000166	0.00145	CbGeAlD
Pazopanib—ABCB1—respiratory system—asthma	0.00016	0.0014	CbGeAlD
Pazopanib—ABCB1—adrenal cortex—asthma	0.000135	0.00117	CbGeAlD
Pazopanib—ABCB1—epithelium—asthma	0.000134	0.00117	CbGeAlD
Pazopanib—ABCB1—cardiovascular system—asthma	0.000123	0.00107	CbGeAlD
Pazopanib—ABCB1—trachea—asthma	0.000118	0.00103	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Hydrocortisone—asthma	0.000107	0.0267	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Hydrocortisone—asthma	0.000107	0.0267	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Methylprednisolone—asthma	0.000101	0.0252	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Methylprednisolone—asthma	0.000101	0.0252	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Dexamethasone—asthma	9.97e-05	0.0248	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Betamethasone—asthma	9.97e-05	0.0248	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Triamcinolone—asthma	9.74e-05	0.0242	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Triamcinolone—asthma	9.74e-05	0.0242	CbGdCrCtD
Pazopanib—ABCB1—adrenal gland—asthma	9.71e-05	0.000847	CbGeAlD
Pazopanib—SH2B3—Dexamethasone—Prednisone—asthma	9.25e-05	0.023	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Prednisone—asthma	9.25e-05	0.023	CbGdCrCtD
Pazopanib—SH2B3—Dexamethasone—Prednisolone—asthma	9.03e-05	0.0224	CbGdCrCtD
Pazopanib—SH2B3—Betamethasone—Prednisolone—asthma	9.03e-05	0.0224	CbGdCrCtD
Pazopanib—ABCB1—lung—asthma	8.51e-05	0.000742	CbGeAlD
Pazopanib—Haemorrhage—Betamethasone—asthma	5.76e-05	0.000277	CcSEcCtD
Pazopanib—Haemorrhage—Dexamethasone—asthma	5.76e-05	0.000277	CcSEcCtD
Pazopanib—Vomiting—Formoterol—asthma	5.75e-05	0.000277	CcSEcCtD
Pazopanib—Vomiting—Arformoterol—asthma	5.75e-05	0.000277	CcSEcCtD
Pazopanib—Angiopathy—Methylprednisolone—asthma	5.74e-05	0.000277	CcSEcCtD
Pazopanib—Nausea—Mometasone—asthma	5.73e-05	0.000276	CcSEcCtD
Pazopanib—Rash—Formoterol—asthma	5.71e-05	0.000275	CcSEcCtD
Pazopanib—Rash—Arformoterol—asthma	5.71e-05	0.000275	CcSEcCtD
Pazopanib—Mediastinal disorder—Methylprednisolone—asthma	5.7e-05	0.000275	CcSEcCtD
Pazopanib—Dermatitis—Arformoterol—asthma	5.7e-05	0.000275	CcSEcCtD
Pazopanib—Dermatitis—Formoterol—asthma	5.7e-05	0.000275	CcSEcCtD
Pazopanib—Headache—Formoterol—asthma	5.67e-05	0.000273	CcSEcCtD
Pazopanib—Headache—Arformoterol—asthma	5.67e-05	0.000273	CcSEcCtD
Pazopanib—Weight decreased—Prednisone—asthma	5.67e-05	0.000273	CcSEcCtD
Pazopanib—Diarrhoea—Budesonide—asthma	5.66e-05	0.000273	CcSEcCtD
Pazopanib—Vision blurred—Prednisolone—asthma	5.66e-05	0.000273	CcSEcCtD
Pazopanib—Dizziness—Salbutamol—asthma	5.65e-05	0.000272	CcSEcCtD
Pazopanib—Vomiting—Montelukast—asthma	5.64e-05	0.000272	CcSEcCtD
Pazopanib—Rash—Montelukast—asthma	5.59e-05	0.000269	CcSEcCtD
Pazopanib—Dermatitis—Montelukast—asthma	5.58e-05	0.000269	CcSEcCtD
Pazopanib—Headache—Montelukast—asthma	5.55e-05	0.000268	CcSEcCtD
Pazopanib—Mental disorder—Methylprednisolone—asthma	5.55e-05	0.000267	CcSEcCtD
Pazopanib—Erythema—Triamcinolone—asthma	5.52e-05	0.000266	CcSEcCtD
Pazopanib—Erythema—Methylprednisolone—asthma	5.51e-05	0.000266	CcSEcCtD
Pazopanib—Malnutrition—Methylprednisolone—asthma	5.51e-05	0.000266	CcSEcCtD
Pazopanib—Acute coronary syndrome—Prednisone—asthma	5.5e-05	0.000265	CcSEcCtD
Pazopanib—Myocardial infarction—Prednisone—asthma	5.47e-05	0.000264	CcSEcCtD
Pazopanib—Dizziness—Budesonide—asthma	5.47e-05	0.000264	CcSEcCtD
Pazopanib—Vomiting—Salbutamol—asthma	5.43e-05	0.000262	CcSEcCtD
Pazopanib—Dysgeusia—Triamcinolone—asthma	5.41e-05	0.000261	CcSEcCtD
Pazopanib—Rash—Salbutamol—asthma	5.39e-05	0.00026	CcSEcCtD
Pazopanib—Syncope—Prednisolone—asthma	5.39e-05	0.00026	CcSEcCtD
Pazopanib—Dermatitis—Salbutamol—asthma	5.38e-05	0.000259	CcSEcCtD
Pazopanib—Eye disorder—Dexamethasone—asthma	5.38e-05	0.000259	CcSEcCtD
Pazopanib—Eye disorder—Betamethasone—asthma	5.38e-05	0.000259	CcSEcCtD
Pazopanib—Nausea—Arformoterol—asthma	5.38e-05	0.000259	CcSEcCtD
Pazopanib—Nausea—Formoterol—asthma	5.38e-05	0.000259	CcSEcCtD
Pazopanib—Headache—Salbutamol—asthma	5.35e-05	0.000258	CcSEcCtD
Pazopanib—Loss of consciousness—Prednisolone—asthma	5.28e-05	0.000254	CcSEcCtD
Pazopanib—Nausea—Montelukast—asthma	5.26e-05	0.000254	CcSEcCtD
Pazopanib—Vomiting—Budesonide—asthma	5.26e-05	0.000254	CcSEcCtD
Pazopanib—Syncope—Hydrocortisone—asthma	5.26e-05	0.000254	CcSEcCtD
Pazopanib—Angiopathy—Dexamethasone—asthma	5.22e-05	0.000252	CcSEcCtD
Pazopanib—Angiopathy—Betamethasone—asthma	5.22e-05	0.000252	CcSEcCtD
Pazopanib—Rash—Budesonide—asthma	5.22e-05	0.000252	CcSEcCtD
Pazopanib—Dermatitis—Budesonide—asthma	5.21e-05	0.000251	CcSEcCtD
Pazopanib—Headache—Budesonide—asthma	5.19e-05	0.00025	CcSEcCtD
Pazopanib—Hypertension—Prednisolone—asthma	5.18e-05	0.00025	CcSEcCtD
Pazopanib—Loss of consciousness—Hydrocortisone—asthma	5.15e-05	0.000248	CcSEcCtD
Pazopanib—Bradycardia—Prednisone—asthma	5.1e-05	0.000246	CcSEcCtD
Pazopanib—Alopecia—Betamethasone—asthma	5.09e-05	0.000245	CcSEcCtD
Pazopanib—Alopecia—Dexamethasone—asthma	5.09e-05	0.000245	CcSEcCtD
Pazopanib—Nausea—Salbutamol—asthma	5.08e-05	0.000245	CcSEcCtD
Pazopanib—Hypertension—Hydrocortisone—asthma	5.06e-05	0.000244	CcSEcCtD
Pazopanib—Haemoglobin—Prednisone—asthma	5.04e-05	0.000243	CcSEcCtD
Pazopanib—Haemorrhage—Prednisone—asthma	5.01e-05	0.000242	CcSEcCtD
Pazopanib—Erythema—Dexamethasone—asthma	5.01e-05	0.000242	CcSEcCtD
Pazopanib—Erythema—Betamethasone—asthma	5.01e-05	0.000242	CcSEcCtD
Pazopanib—Myalgia—Hydrocortisone—asthma	4.99e-05	0.000241	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—asthma	4.96e-05	0.000239	CcSEcCtD
Pazopanib—Syncope—Triamcinolone—asthma	4.95e-05	0.000239	CcSEcCtD
Pazopanib—Syncope—Methylprednisolone—asthma	4.94e-05	0.000238	CcSEcCtD
Pazopanib—Connective tissue disorder—Prednisone—asthma	4.93e-05	0.000237	CcSEcCtD
Pazopanib—Nausea—Budesonide—asthma	4.92e-05	0.000237	CcSEcCtD
Pazopanib—Oedema—Prednisolone—asthma	4.9e-05	0.000236	CcSEcCtD
Pazopanib—Loss of consciousness—Triamcinolone—asthma	4.85e-05	0.000234	CcSEcCtD
Pazopanib—Loss of consciousness—Methylprednisolone—asthma	4.84e-05	0.000233	CcSEcCtD
Pazopanib—Shock—Prednisolone—asthma	4.82e-05	0.000232	CcSEcCtD
Pazopanib—Cough—Triamcinolone—asthma	4.82e-05	0.000232	CcSEcCtD
Pazopanib—Oedema—Hydrocortisone—asthma	4.79e-05	0.000231	CcSEcCtD
Pazopanib—Hypertension—Triamcinolone—asthma	4.77e-05	0.00023	CcSEcCtD
Pazopanib—Hypertension—Methylprednisolone—asthma	4.76e-05	0.000229	CcSEcCtD
Pazopanib—Infection—Hydrocortisone—asthma	4.76e-05	0.000229	CcSEcCtD
Pazopanib—Hyperhidrosis—Prednisolone—asthma	4.74e-05	0.000228	CcSEcCtD
Pazopanib—Shock—Hydrocortisone—asthma	4.71e-05	0.000227	CcSEcCtD
Pazopanib—Myalgia—Triamcinolone—asthma	4.7e-05	0.000227	CcSEcCtD
Pazopanib—Nervous system disorder—Hydrocortisone—asthma	4.69e-05	0.000226	CcSEcCtD
Pazopanib—Myalgia—Methylprednisolone—asthma	4.69e-05	0.000226	CcSEcCtD
Pazopanib—Arthralgia—Methylprednisolone—asthma	4.69e-05	0.000226	CcSEcCtD
Pazopanib—Eye disorder—Prednisone—asthma	4.68e-05	0.000226	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—asthma	4.66e-05	0.000225	CcSEcCtD
Pazopanib—Flushing—Prednisone—asthma	4.65e-05	0.000224	CcSEcCtD
Pazopanib—Skin disorder—Hydrocortisone—asthma	4.65e-05	0.000224	CcSEcCtD
Pazopanib—Hyperhidrosis—Hydrocortisone—asthma	4.63e-05	0.000223	CcSEcCtD
Pazopanib—Dry mouth—Triamcinolone—asthma	4.6e-05	0.000222	CcSEcCtD
Pazopanib—Anorexia—Hydrocortisone—asthma	4.56e-05	0.00022	CcSEcCtD
Pazopanib—Angiopathy—Prednisone—asthma	4.55e-05	0.000219	CcSEcCtD
Pazopanib—Oedema—Triamcinolone—asthma	4.51e-05	0.000217	CcSEcCtD
Pazopanib—Syncope—Dexamethasone—asthma	4.49e-05	0.000217	CcSEcCtD
Pazopanib—Syncope—Betamethasone—asthma	4.49e-05	0.000217	CcSEcCtD
Pazopanib—Infection—Triamcinolone—asthma	4.48e-05	0.000216	CcSEcCtD
Pazopanib—Infection—Methylprednisolone—asthma	4.47e-05	0.000215	CcSEcCtD
Pazopanib—Shock—Triamcinolone—asthma	4.43e-05	0.000214	CcSEcCtD
Pazopanib—Insomnia—Prednisolone—asthma	4.43e-05	0.000214	CcSEcCtD
Pazopanib—Alopecia—Prednisone—asthma	4.43e-05	0.000214	CcSEcCtD
Pazopanib—Shock—Methylprednisolone—asthma	4.42e-05	0.000213	CcSEcCtD
Pazopanib—Nervous system disorder—Methylprednisolone—asthma	4.41e-05	0.000213	CcSEcCtD
Pazopanib—Loss of consciousness—Dexamethasone—asthma	4.4e-05	0.000212	CcSEcCtD
Pazopanib—Loss of consciousness—Betamethasone—asthma	4.4e-05	0.000212	CcSEcCtD
Pazopanib—Paraesthesia—Prednisolone—asthma	4.4e-05	0.000212	CcSEcCtD
Pazopanib—Mental disorder—Prednisone—asthma	4.39e-05	0.000212	CcSEcCtD
Pazopanib—Skin disorder—Methylprednisolone—asthma	4.37e-05	0.000211	CcSEcCtD
Pazopanib—Malnutrition—Prednisone—asthma	4.36e-05	0.00021	CcSEcCtD
Pazopanib—Erythema—Prednisone—asthma	4.36e-05	0.00021	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Hydrocortisone—asthma	4.36e-05	0.00021	CcSEcCtD
Pazopanib—Hyperhidrosis—Triamcinolone—asthma	4.36e-05	0.00021	CcSEcCtD
Pazopanib—Hyperhidrosis—Methylprednisolone—asthma	4.35e-05	0.00021	CcSEcCtD
Pazopanib—Insomnia—Hydrocortisone—asthma	4.33e-05	0.000209	CcSEcCtD
Pazopanib—Hypertension—Betamethasone—asthma	4.33e-05	0.000209	CcSEcCtD
Pazopanib—Hypertension—Dexamethasone—asthma	4.33e-05	0.000209	CcSEcCtD
Pazopanib—Paraesthesia—Hydrocortisone—asthma	4.3e-05	0.000207	CcSEcCtD
Pazopanib—Myalgia—Dexamethasone—asthma	4.27e-05	0.000206	CcSEcCtD
Pazopanib—Myalgia—Betamethasone—asthma	4.27e-05	0.000206	CcSEcCtD
Pazopanib—Dyspepsia—Hydrocortisone—asthma	4.21e-05	0.000203	CcSEcCtD
Pazopanib—Pain—Prednisolone—asthma	4.19e-05	0.000202	CcSEcCtD
Pazopanib—Decreased appetite—Hydrocortisone—asthma	4.16e-05	0.000201	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Hydrocortisone—asthma	4.13e-05	0.000199	CcSEcCtD
Pazopanib—Fatigue—Hydrocortisone—asthma	4.13e-05	0.000199	CcSEcCtD
Pazopanib—Vision blurred—Prednisone—asthma	4.11e-05	0.000198	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Triamcinolone—asthma	4.11e-05	0.000198	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Methylprednisolone—asthma	4.1e-05	0.000197	CcSEcCtD
Pazopanib—Pain—Hydrocortisone—asthma	4.09e-05	0.000197	CcSEcCtD
Pazopanib—Oedema—Dexamethasone—asthma	4.09e-05	0.000197	CcSEcCtD
Pazopanib—Oedema—Betamethasone—asthma	4.09e-05	0.000197	CcSEcCtD
Pazopanib—Insomnia—Triamcinolone—asthma	4.08e-05	0.000196	CcSEcCtD
Pazopanib—Insomnia—Methylprednisolone—asthma	4.07e-05	0.000196	CcSEcCtD
Pazopanib—Infection—Betamethasone—asthma	4.06e-05	0.000196	CcSEcCtD
Pazopanib—Infection—Dexamethasone—asthma	4.06e-05	0.000196	CcSEcCtD
Pazopanib—Paraesthesia—Triamcinolone—asthma	4.05e-05	0.000195	CcSEcCtD
Pazopanib—Paraesthesia—Methylprednisolone—asthma	4.04e-05	0.000195	CcSEcCtD
Pazopanib—Anaemia—Prednisone—asthma	4.03e-05	0.000194	CcSEcCtD
Pazopanib—Shock—Dexamethasone—asthma	4.02e-05	0.000194	CcSEcCtD
Pazopanib—Shock—Betamethasone—asthma	4.02e-05	0.000194	CcSEcCtD
Pazopanib—Dyspnoea—Triamcinolone—asthma	4.02e-05	0.000194	CcSEcCtD
Pazopanib—Nervous system disorder—Dexamethasone—asthma	4.01e-05	0.000193	CcSEcCtD
Pazopanib—Nervous system disorder—Betamethasone—asthma	4.01e-05	0.000193	CcSEcCtD
Pazopanib—Thrombocytopenia—Dexamethasone—asthma	4e-05	0.000193	CcSEcCtD
Pazopanib—Thrombocytopenia—Betamethasone—asthma	4e-05	0.000193	CcSEcCtD
Pazopanib—Dyspepsia—Triamcinolone—asthma	3.97e-05	0.000191	CcSEcCtD
Pazopanib—Dyspepsia—Methylprednisolone—asthma	3.96e-05	0.000191	CcSEcCtD
Pazopanib—Hyperhidrosis—Dexamethasone—asthma	3.95e-05	0.000191	CcSEcCtD
Pazopanib—Hyperhidrosis—Betamethasone—asthma	3.95e-05	0.000191	CcSEcCtD
Pazopanib—Gastrointestinal pain—Hydrocortisone—asthma	3.91e-05	0.000189	CcSEcCtD
Pazopanib—Syncope—Prednisone—asthma	3.91e-05	0.000189	CcSEcCtD
Pazopanib—Anorexia—Betamethasone—asthma	3.9e-05	0.000188	CcSEcCtD
Pazopanib—Anorexia—Dexamethasone—asthma	3.9e-05	0.000188	CcSEcCtD
Pazopanib—Fatigue—Triamcinolone—asthma	3.89e-05	0.000187	CcSEcCtD
Pazopanib—Fatigue—Methylprednisolone—asthma	3.88e-05	0.000187	CcSEcCtD
Pazopanib—Pain—Triamcinolone—asthma	3.85e-05	0.000186	CcSEcCtD
Pazopanib—Loss of consciousness—Prednisone—asthma	3.84e-05	0.000185	CcSEcCtD
Pazopanib—Abdominal pain—Hydrocortisone—asthma	3.78e-05	0.000182	CcSEcCtD
Pazopanib—Hypertension—Prednisone—asthma	3.77e-05	0.000182	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Dexamethasone—asthma	3.73e-05	0.00018	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Betamethasone—asthma	3.73e-05	0.00018	CcSEcCtD
Pazopanib—Arthralgia—Prednisone—asthma	3.72e-05	0.000179	CcSEcCtD
Pazopanib—Myalgia—Prednisone—asthma	3.72e-05	0.000179	CcSEcCtD
Pazopanib—Insomnia—Dexamethasone—asthma	3.7e-05	0.000178	CcSEcCtD
Pazopanib—Insomnia—Betamethasone—asthma	3.7e-05	0.000178	CcSEcCtD
Pazopanib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—asthma	3.69e-05	0.000178	CcSEcCtD
Pazopanib—Gastrointestinal pain—Methylprednisolone—asthma	3.68e-05	0.000177	CcSEcCtD
Pazopanib—Paraesthesia—Dexamethasone—asthma	3.67e-05	0.000177	CcSEcCtD
Pazopanib—Paraesthesia—Betamethasone—asthma	3.67e-05	0.000177	CcSEcCtD
Pazopanib—Dyspepsia—Betamethasone—asthma	3.6e-05	0.000174	CcSEcCtD
Pazopanib—Dyspepsia—Dexamethasone—asthma	3.6e-05	0.000174	CcSEcCtD
Pazopanib—Oedema—Prednisone—asthma	3.56e-05	0.000172	CcSEcCtD
Pazopanib—Abdominal pain—Methylprednisolone—asthma	3.55e-05	0.000171	CcSEcCtD
Pazopanib—Decreased appetite—Betamethasone—asthma	3.55e-05	0.000171	CcSEcCtD
Pazopanib—Decreased appetite—Dexamethasone—asthma	3.55e-05	0.000171	CcSEcCtD
Pazopanib—Infection—Prednisone—asthma	3.54e-05	0.000171	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Betamethasone—asthma	3.53e-05	0.00017	CcSEcCtD
Pazopanib—Gastrointestinal disorder—Dexamethasone—asthma	3.53e-05	0.00017	CcSEcCtD
Pazopanib—Fatigue—Dexamethasone—asthma	3.53e-05	0.00017	CcSEcCtD
Pazopanib—Fatigue—Betamethasone—asthma	3.53e-05	0.00017	CcSEcCtD
Pazopanib—Shock—Prednisone—asthma	3.5e-05	0.000169	CcSEcCtD
Pazopanib—Pain—Dexamethasone—asthma	3.5e-05	0.000169	CcSEcCtD
Pazopanib—Pain—Betamethasone—asthma	3.5e-05	0.000169	CcSEcCtD
Pazopanib—Nervous system disorder—Prednisone—asthma	3.49e-05	0.000168	CcSEcCtD
Pazopanib—Skin disorder—Prednisone—asthma	3.46e-05	0.000167	CcSEcCtD
Pazopanib—Hyperhidrosis—Prednisone—asthma	3.44e-05	0.000166	CcSEcCtD
Pazopanib—Asthenia—Hydrocortisone—asthma	3.43e-05	0.000166	CcSEcCtD
Pazopanib—Anorexia—Prednisone—asthma	3.39e-05	0.000164	CcSEcCtD
Pazopanib—Pruritus—Hydrocortisone—asthma	3.39e-05	0.000163	CcSEcCtD
Pazopanib—Gastrointestinal pain—Dexamethasone—asthma	3.34e-05	0.000161	CcSEcCtD
Pazopanib—Gastrointestinal pain—Betamethasone—asthma	3.34e-05	0.000161	CcSEcCtD
Pazopanib—Diarrhoea—Hydrocortisone—asthma	3.27e-05	0.000158	CcSEcCtD
Pazopanib—Musculoskeletal discomfort—Prednisone—asthma	3.24e-05	0.000156	CcSEcCtD
Pazopanib—Dizziness—Prednisolone—asthma	3.24e-05	0.000156	CcSEcCtD
Pazopanib—Asthenia—Triamcinolone—asthma	3.23e-05	0.000156	CcSEcCtD
Pazopanib—Abdominal pain—Dexamethasone—asthma	3.23e-05	0.000156	CcSEcCtD
Pazopanib—Abdominal pain—Betamethasone—asthma	3.23e-05	0.000156	CcSEcCtD
Pazopanib—Asthenia—Methylprednisolone—asthma	3.23e-05	0.000156	CcSEcCtD
Pazopanib—Insomnia—Prednisone—asthma	3.22e-05	0.000155	CcSEcCtD
Pazopanib—Paraesthesia—Prednisone—asthma	3.2e-05	0.000154	CcSEcCtD
Pazopanib—Pruritus—Triamcinolone—asthma	3.19e-05	0.000154	CcSEcCtD
Pazopanib—Pruritus—Methylprednisolone—asthma	3.18e-05	0.000153	CcSEcCtD
Pazopanib—Dizziness—Hydrocortisone—asthma	3.17e-05	0.000153	CcSEcCtD
Pazopanib—Dyspepsia—Prednisone—asthma	3.13e-05	0.000151	CcSEcCtD
Pazopanib—Decreased appetite—Prednisone—asthma	3.1e-05	0.000149	CcSEcCtD
Pazopanib—Rash—Prednisolone—asthma	3.09e-05	0.000149	CcSEcCtD
Pazopanib—Dermatitis—Prednisolone—asthma	3.09e-05	0.000149	CcSEcCtD
Pazopanib—Diarrhoea—Methylprednisolone—asthma	3.08e-05	0.000148	CcSEcCtD
Pazopanib—Fatigue—Prednisone—asthma	3.07e-05	0.000148	CcSEcCtD
Pazopanib—Headache—Prednisolone—asthma	3.07e-05	0.000148	CcSEcCtD
Pazopanib—Vomiting—Hydrocortisone—asthma	3.04e-05	0.000147	CcSEcCtD
Pazopanib—Rash—Hydrocortisone—asthma	3.02e-05	0.000145	CcSEcCtD
Pazopanib—Dermatitis—Hydrocortisone—asthma	3.02e-05	0.000145	CcSEcCtD
Pazopanib—Headache—Hydrocortisone—asthma	3e-05	0.000145	CcSEcCtD
Pazopanib—Dizziness—Triamcinolone—asthma	2.98e-05	0.000144	CcSEcCtD
Pazopanib—Dizziness—Methylprednisolone—asthma	2.97e-05	0.000143	CcSEcCtD
Pazopanib—Asthenia—Betamethasone—asthma	2.93e-05	0.000141	CcSEcCtD
Pazopanib—Asthenia—Dexamethasone—asthma	2.93e-05	0.000141	CcSEcCtD
Pazopanib—Gastrointestinal pain—Prednisone—asthma	2.91e-05	0.00014	CcSEcCtD
Pazopanib—Nausea—Prednisolone—asthma	2.91e-05	0.00014	CcSEcCtD
Pazopanib—Pruritus—Dexamethasone—asthma	2.89e-05	0.000139	CcSEcCtD
Pazopanib—Pruritus—Betamethasone—asthma	2.89e-05	0.000139	CcSEcCtD
Pazopanib—Vomiting—Triamcinolone—asthma	2.87e-05	0.000138	CcSEcCtD
Pazopanib—Vomiting—Methylprednisolone—asthma	2.86e-05	0.000138	CcSEcCtD
Pazopanib—Nausea—Hydrocortisone—asthma	2.84e-05	0.000137	CcSEcCtD
Pazopanib—Rash—Triamcinolone—asthma	2.84e-05	0.000137	CcSEcCtD
Pazopanib—Dermatitis—Triamcinolone—asthma	2.84e-05	0.000137	CcSEcCtD
Pazopanib—Rash—Methylprednisolone—asthma	2.84e-05	0.000137	CcSEcCtD
Pazopanib—Dermatitis—Methylprednisolone—asthma	2.83e-05	0.000137	CcSEcCtD
Pazopanib—Headache—Triamcinolone—asthma	2.82e-05	0.000136	CcSEcCtD
Pazopanib—Headache—Methylprednisolone—asthma	2.82e-05	0.000136	CcSEcCtD
Pazopanib—Abdominal pain—Prednisone—asthma	2.82e-05	0.000136	CcSEcCtD
Pazopanib—Diarrhoea—Dexamethasone—asthma	2.8e-05	0.000135	CcSEcCtD
Pazopanib—Diarrhoea—Betamethasone—asthma	2.8e-05	0.000135	CcSEcCtD
Pazopanib—Dizziness—Betamethasone—asthma	2.7e-05	0.00013	CcSEcCtD
Pazopanib—Dizziness—Dexamethasone—asthma	2.7e-05	0.00013	CcSEcCtD
Pazopanib—Nausea—Triamcinolone—asthma	2.68e-05	0.000129	CcSEcCtD
Pazopanib—Nausea—Methylprednisolone—asthma	2.67e-05	0.000129	CcSEcCtD
Pazopanib—Vomiting—Dexamethasone—asthma	2.6e-05	0.000125	CcSEcCtD
Pazopanib—Vomiting—Betamethasone—asthma	2.6e-05	0.000125	CcSEcCtD
Pazopanib—Rash—Betamethasone—asthma	2.58e-05	0.000124	CcSEcCtD
Pazopanib—Rash—Dexamethasone—asthma	2.58e-05	0.000124	CcSEcCtD
Pazopanib—Dermatitis—Betamethasone—asthma	2.58e-05	0.000124	CcSEcCtD
Pazopanib—Dermatitis—Dexamethasone—asthma	2.58e-05	0.000124	CcSEcCtD
Pazopanib—Headache—Dexamethasone—asthma	2.56e-05	0.000123	CcSEcCtD
Pazopanib—Headache—Betamethasone—asthma	2.56e-05	0.000123	CcSEcCtD
Pazopanib—Asthenia—Prednisone—asthma	2.56e-05	0.000123	CcSEcCtD
Pazopanib—Pruritus—Prednisone—asthma	2.52e-05	0.000121	CcSEcCtD
Pazopanib—Diarrhoea—Prednisone—asthma	2.44e-05	0.000117	CcSEcCtD
Pazopanib—Nausea—Dexamethasone—asthma	2.43e-05	0.000117	CcSEcCtD
Pazopanib—Nausea—Betamethasone—asthma	2.43e-05	0.000117	CcSEcCtD
Pazopanib—Dizziness—Prednisone—asthma	2.36e-05	0.000114	CcSEcCtD
Pazopanib—Vomiting—Prednisone—asthma	2.26e-05	0.000109	CcSEcCtD
Pazopanib—Rash—Prednisone—asthma	2.25e-05	0.000108	CcSEcCtD
Pazopanib—Dermatitis—Prednisone—asthma	2.24e-05	0.000108	CcSEcCtD
Pazopanib—Headache—Prednisone—asthma	2.23e-05	0.000108	CcSEcCtD
Pazopanib—Nausea—Prednisone—asthma	2.12e-05	0.000102	CcSEcCtD
Pazopanib—PDGFRB—Disease—PTEN—asthma	2.68e-06	1.55e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—STAT3—asthma	2.67e-06	1.54e-05	CbGpPWpGaD
Pazopanib—FLT1—Signaling Pathways—IL6—asthma	2.67e-06	1.54e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—STAT3—asthma	2.67e-06	1.54e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—TGFB1—asthma	2.66e-06	1.54e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—EGFR—asthma	2.65e-06	1.53e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—RHOA—asthma	2.65e-06	1.53e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—POMC—asthma	2.65e-06	1.53e-05	CbGpPWpGaD
Pazopanib—ABCB1—Transmembrane transport of small molecules—ALB—asthma	2.64e-06	1.53e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CCL2—asthma	2.64e-06	1.53e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—RHOA—asthma	2.64e-06	1.53e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CARM1—asthma	2.64e-06	1.53e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PDGFB—asthma	2.64e-06	1.53e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6R—asthma	2.64e-06	1.52e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—VEGFA—asthma	2.64e-06	1.52e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—EGFR—asthma	2.63e-06	1.52e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—EGFR—asthma	2.62e-06	1.52e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—NOS3—asthma	2.62e-06	1.52e-05	CbGpPWpGaD
Pazopanib—FGF1—Immune System—IL6—asthma	2.62e-06	1.51e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—NOS3—asthma	2.62e-06	1.51e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—TGFB1—asthma	2.61e-06	1.51e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—STAT3—asthma	2.61e-06	1.51e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—EGFR—asthma	2.61e-06	1.51e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—DCN—asthma	2.6e-06	1.5e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—STAT3—asthma	2.6e-06	1.5e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CCL2—asthma	2.59e-06	1.5e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—NOS3—asthma	2.58e-06	1.49e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6R—asthma	2.58e-06	1.49e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—VEGFA—asthma	2.57e-06	1.48e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—EGFR—asthma	2.56e-06	1.48e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—STAT3—asthma	2.55e-06	1.47e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—STAT3—asthma	2.54e-06	1.47e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALDH2—asthma	2.53e-06	1.46e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—LEP—asthma	2.53e-06	1.46e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALOX5AP—asthma	2.51e-06	1.45e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALOX15—asthma	2.51e-06	1.45e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—POMC—asthma	2.51e-06	1.45e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NQO1—asthma	2.51e-06	1.45e-05	CbGpPWpGaD
Pazopanib—LCK—Innate Immune System—IL6—asthma	2.5e-06	1.45e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—CXCL8—asthma	2.5e-06	1.44e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL1B—asthma	2.49e-06	1.44e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—CD4—asthma	2.49e-06	1.44e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL2—asthma	2.48e-06	1.43e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—TGFB1—asthma	2.48e-06	1.43e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—ALB—asthma	2.47e-06	1.43e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—TGFB1—asthma	2.47e-06	1.43e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTGS2—asthma	2.47e-06	1.43e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—SERPINE1—asthma	2.47e-06	1.43e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ADCY2—asthma	2.45e-06	1.42e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—CXCL8—asthma	2.45e-06	1.42e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—VEGFA—asthma	2.45e-06	1.42e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—asthma	2.44e-06	1.41e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—POMC—asthma	2.44e-06	1.41e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—EGFR—asthma	2.43e-06	1.4e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—STAT3—asthma	2.43e-06	1.4e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—EGFR—asthma	2.42e-06	1.4e-05	CbGpPWpGaD
Pazopanib—FGF1—Disease—IL6—asthma	2.42e-06	1.4e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—TGFB1—asthma	2.42e-06	1.4e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—SERPINE1—asthma	2.42e-06	1.4e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTT1—asthma	2.41e-06	1.39e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—STAT3—asthma	2.4e-06	1.39e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GSTP1—asthma	2.4e-06	1.39e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CHAT—asthma	2.4e-06	1.39e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL2—asthma	2.39e-06	1.38e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—RHOA—asthma	2.38e-06	1.38e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—FN1—asthma	2.38e-06	1.38e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—EGFR—asthma	2.37e-06	1.37e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—HMOX1—asthma	2.37e-06	1.37e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—NOS3—asthma	2.37e-06	1.37e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—EGFR—asthma	2.36e-06	1.37e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NQO1—asthma	2.36e-06	1.37e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ITPR1—asthma	2.36e-06	1.37e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTGS2—asthma	2.36e-06	1.37e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—TGFB1—asthma	2.36e-06	1.36e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—NOS3—asthma	2.36e-06	1.36e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL2—asthma	2.34e-06	1.35e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—CAT—asthma	2.34e-06	1.35e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—PTEN—asthma	2.33e-06	1.35e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—RHOA—asthma	2.33e-06	1.35e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—CXCL8—asthma	2.33e-06	1.34e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—CXCL8—asthma	2.32e-06	1.34e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—EGFR—asthma	2.31e-06	1.34e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ADCY2—asthma	2.31e-06	1.34e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—EGFR—asthma	2.31e-06	1.34e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—NOS3—asthma	2.31e-06	1.33e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—ALB—asthma	2.29e-06	1.32e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—MMP9—asthma	2.26e-06	1.3e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—TGFB1—asthma	2.25e-06	1.3e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—PTEN—asthma	2.24e-06	1.3e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—TGFB1—asthma	2.23e-06	1.29e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL2—asthma	2.22e-06	1.29e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—ALB—asthma	2.22e-06	1.28e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL2—asthma	2.22e-06	1.28e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—MMP9—asthma	2.22e-06	1.28e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PLA2G4A—asthma	2.21e-06	1.28e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—GSTM1—asthma	2.21e-06	1.28e-05	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—EGFR—asthma	2.2e-06	1.27e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—PTEN—asthma	2.2e-06	1.27e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—NOS3—asthma	2.19e-06	1.27e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—EGFR—asthma	2.18e-06	1.26e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—POMC—asthma	2.17e-06	1.25e-05	CbGpPWpGaD
Pazopanib—FGFR2—Immune System—IL6—asthma	2.17e-06	1.25e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTGS2—asthma	2.16e-06	1.25e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—PTEN—asthma	2.15e-06	1.25e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALOX5—asthma	2.14e-06	1.24e-05	CbGpPWpGaD
Pazopanib—KIT—Immune System—IL6—asthma	2.13e-06	1.23e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CCL2—asthma	2.12e-06	1.23e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6R—asthma	2.12e-06	1.22e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—MMP9—asthma	2.1e-06	1.22e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—MMP9—asthma	2.1e-06	1.21e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—PTEN—asthma	2.09e-06	1.21e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTP1—asthma	2.09e-06	1.21e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—CXCL8—asthma	2.09e-06	1.21e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—STAT3—asthma	2.09e-06	1.21e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—PTEN—asthma	2.09e-06	1.21e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—HMOX1—asthma	2.06e-06	1.19e-05	CbGpPWpGaD
Pazopanib—UGT1A1—Metabolism—PTEN—asthma	2.06e-06	1.19e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ITPR1—asthma	2.06e-06	1.19e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—CXCL8—asthma	2.05e-06	1.18e-05	CbGpPWpGaD
Pazopanib—FGFR3—Signaling Pathways—IL6—asthma	2.04e-06	1.18e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CARM1—asthma	2.04e-06	1.18e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—CAT—asthma	2.04e-06	1.18e-05	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PPP2CA—asthma	2.03e-06	1.17e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—VEGFA—asthma	2.03e-06	1.17e-05	CbGpPWpGaD
Pazopanib—FGFR1—Immune System—IL6—asthma	2.02e-06	1.17e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Immune System—IL6—asthma	2.02e-06	1.17e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—DCN—asthma	2.01e-06	1.16e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—STAT3—asthma	2.01e-06	1.16e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTGS2—asthma	2e-06	1.16e-05	CbGpPWpGaD
Pazopanib—FGFR2—Disease—IL6—asthma	2e-06	1.16e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NQO1—asthma	2e-06	1.16e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL2—asthma	2e-06	1.15e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—VEGFA—asthma	1.99e-06	1.15e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—SERPINE1—asthma	1.98e-06	1.15e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—STAT3—asthma	1.97e-06	1.14e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTP1—asthma	1.97e-06	1.14e-05	CbGpPWpGaD
Pazopanib—KIT—Disease—IL6—asthma	1.97e-06	1.14e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ADCY2—asthma	1.96e-06	1.13e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL2—asthma	1.96e-06	1.13e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALDH2—asthma	1.95e-06	1.13e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—HMOX1—asthma	1.94e-06	1.12e-05	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—asthma	1.94e-06	1.12e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ITPR1—asthma	1.94e-06	1.12e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—STAT3—asthma	1.93e-06	1.11e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—GSTM1—asthma	1.92e-06	1.11e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PLA2G4A—asthma	1.92e-06	1.11e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—CAT—asthma	1.92e-06	1.11e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—RHOA—asthma	1.91e-06	1.1e-05	CbGpPWpGaD
Pazopanib—LCK—Immune System—EGFR—asthma	1.9e-06	1.1e-05	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—NOS3—asthma	1.89e-06	1.09e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—MMP9—asthma	1.89e-06	1.09e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—VEGFA—asthma	1.89e-06	1.09e-05	CbGpPWpGaD
Pazopanib—SLCO1B1—Metabolism—PTEN—asthma	1.89e-06	1.09e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—VEGFA—asthma	1.89e-06	1.09e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—PTEN—asthma	1.88e-06	1.09e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—STAT3—asthma	1.87e-06	1.08e-05	CbGpPWpGaD
Pazopanib—FGFR1—Disease—IL6—asthma	1.87e-06	1.08e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—STAT3—asthma	1.87e-06	1.08e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Disease—IL6—asthma	1.86e-06	1.08e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—TGFB1—asthma	1.86e-06	1.08e-05	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTT1—asthma	1.86e-06	1.07e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—MMP9—asthma	1.85e-06	1.07e-05	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—PTEN—asthma	1.84e-06	1.06e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—TGFB1—asthma	1.83e-06	1.06e-05	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—EGFR—asthma	1.82e-06	1.05e-05	CbGpPWpGaD
Pazopanib—MAP2K5—Signaling Pathways—IL6—asthma	1.82e-06	1.05e-05	CbGpPWpGaD
Pazopanib—PDGFRB—Immune System—IL6—asthma	1.82e-06	1.05e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PLA2G4A—asthma	1.81e-06	1.05e-05	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—GSTM1—asthma	1.81e-06	1.05e-05	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—EGFR—asthma	1.79e-06	1.04e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—TGFB1—asthma	1.79e-06	1.03e-05	CbGpPWpGaD
Pazopanib—LYN—Immune System—IL6—asthma	1.78e-06	1.03e-05	CbGpPWpGaD
Pazopanib—KDR—Signaling Pathways—IL6—asthma	1.78e-06	1.03e-05	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PPP2CA—asthma	1.77e-06	1.02e-05	CbGpPWpGaD
Pazopanib—LCK—Disease—EGFR—asthma	1.75e-06	1.01e-05	CbGpPWpGaD
Pazopanib—ABCG2—Metabolism—PTEN—asthma	1.75e-06	1.01e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—TGFB1—asthma	1.73e-06	1e-05	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—TGFB1—asthma	1.73e-06	1e-05	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—EGFR—asthma	1.7e-06	9.83e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—VEGFA—asthma	1.7e-06	9.81e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—EGFR—asthma	1.7e-06	9.8e-06	CbGpPWpGaD
Pazopanib—FGF1—Signaling Pathways—IL6—asthma	1.69e-06	9.79e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—asthma	1.69e-06	9.79e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—STAT3—asthma	1.68e-06	9.72e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—CXCL8—asthma	1.68e-06	9.7e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Disease—IL6—asthma	1.68e-06	9.69e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTP1—asthma	1.67e-06	9.65e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PPP2CA—asthma	1.67e-06	9.64e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—VEGFA—asthma	1.66e-06	9.61e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—HMOX1—asthma	1.65e-06	9.52e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—STAT3—asthma	1.65e-06	9.51e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ITPR1—asthma	1.64e-06	9.5e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—CAT—asthma	1.62e-06	9.39e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL2—asthma	1.6e-06	9.27e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—POMC—asthma	1.56e-06	9.01e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—TGFB1—asthma	1.56e-06	9.01e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NQO1—asthma	1.55e-06	8.93e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PLA2G4A—asthma	1.53e-06	8.87e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—GSTM1—asthma	1.53e-06	8.87e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—EGFR—asthma	1.53e-06	8.83e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—TGFB1—asthma	1.53e-06	8.82e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—MMP9—asthma	1.52e-06	8.77e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ADCY2—asthma	1.51e-06	8.74e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—PTEN—asthma	1.51e-06	8.72e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—EGFR—asthma	1.5e-06	8.65e-06	CbGpPWpGaD
Pazopanib—LCK—Immune System—IL6—asthma	1.46e-06	8.42e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—ALB—asthma	1.42e-06	8.22e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PPP2CA—asthma	1.41e-06	8.17e-06	CbGpPWpGaD
Pazopanib—FGFR2—Signaling Pathways—IL6—asthma	1.4e-06	8.1e-06	CbGpPWpGaD
Pazopanib—KIT—Signaling Pathways—IL6—asthma	1.38e-06	7.96e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—VEGFA—asthma	1.36e-06	7.88e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—NOS3—asthma	1.36e-06	7.86e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—POMC—asthma	1.36e-06	7.85e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—STAT3—asthma	1.35e-06	7.8e-06	CbGpPWpGaD
Pazopanib—LCK—Disease—IL6—asthma	1.35e-06	7.78e-06	CbGpPWpGaD
Pazopanib—FGFR1—Signaling Pathways—IL6—asthma	1.31e-06	7.55e-06	CbGpPWpGaD
Pazopanib—PDGFRA—Signaling Pathways—IL6—asthma	1.3e-06	7.53e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTP1—asthma	1.29e-06	7.45e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—POMC—asthma	1.28e-06	7.4e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—HMOX1—asthma	1.27e-06	7.35e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ITPR1—asthma	1.27e-06	7.33e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—CAT—asthma	1.25e-06	7.25e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—TGFB1—asthma	1.25e-06	7.23e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTGS2—asthma	1.24e-06	7.19e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—ALB—asthma	1.24e-06	7.16e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—EGFR—asthma	1.23e-06	7.09e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—NOS3—asthma	1.18e-06	6.85e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PLA2G4A—asthma	1.18e-06	6.84e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—GSTM1—asthma	1.18e-06	6.84e-06	CbGpPWpGaD
Pazopanib—PDGFRB—Signaling Pathways—IL6—asthma	1.17e-06	6.79e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—ALB—asthma	1.17e-06	6.75e-06	CbGpPWpGaD
Pazopanib—LYN—Signaling Pathways—IL6—asthma	1.15e-06	6.65e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—NOS3—asthma	1.12e-06	6.45e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PPP2CA—asthma	1.09e-06	6.3e-06	CbGpPWpGaD
Pazopanib—CYP2C8—Metabolism—PTEN—asthma	1.08e-06	6.27e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—POMC—asthma	1.08e-06	6.27e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTGS2—asthma	1.08e-06	6.26e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTGS2—asthma	1.02e-06	5.9e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—ALB—asthma	9.89e-07	5.71e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—NOS3—asthma	9.46e-07	5.47e-06	CbGpPWpGaD
Pazopanib—ABCB1—Metabolism—PTEN—asthma	9.45e-07	5.46e-06	CbGpPWpGaD
Pazopanib—LCK—Signaling Pathways—IL6—asthma	9.43e-07	5.45e-06	CbGpPWpGaD
Pazopanib—CYP2D6—Metabolism—PTEN—asthma	8.91e-07	5.15e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTGS2—asthma	8.65e-07	5e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—POMC—asthma	8.37e-07	4.84e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—ALB—asthma	7.63e-07	4.41e-06	CbGpPWpGaD
Pazopanib—CYP1A2—Metabolism—PTEN—asthma	7.54e-07	4.36e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—NOS3—asthma	7.3e-07	4.22e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTGS2—asthma	6.68e-07	3.86e-06	CbGpPWpGaD
Pazopanib—CYP3A4—Metabolism—PTEN—asthma	5.82e-07	3.36e-06	CbGpPWpGaD
